Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR11506
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Koshiba, Seizo; Tochio, Naoya; Yokoyama, Jun; Yoon, Ho Sup; Kigawa, Takanori. "A strategy for structure determination of large molecular weight protein using isotope labeling methodology with cell-free protein systhesis: application to 45 kDa human vaccinia related kianse 1 (VRK1)" .
Assembly members:
entity, polymer, 403 residues, 46071.996 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: E. coli - cell free Vector: P060908-04
Data type | Count |
13C chemical shifts | 1305 |
15N chemical shifts | 349 |
1H chemical shifts | 947 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | entity | 1 |
Entity 1, entity 403 residues - 46071.996 Da.
1 | GLY | SER | SER | GLY | SER | SER | GLY | MET | PRO | ARG | ||||
2 | VAL | LYS | ALA | ALA | GLN | ALA | GLY | ARG | GLN | SER | ||||
3 | SER | ALA | LYS | ARG | HIS | LEU | ALA | GLU | GLN | PHE | ||||
4 | ALA | VAL | GLY | GLU | ILE | ILE | THR | ASP | MET | ALA | ||||
5 | LYS | LYS | GLU | TRP | LYS | VAL | GLY | LEU | PRO | ILE | ||||
6 | GLY | GLN | GLY | GLY | PHE | GLY | CYS | ILE | TYR | LEU | ||||
7 | ALA | ASP | MET | ASN | SER | SER | GLU | SER | VAL | GLY | ||||
8 | SER | ASP | ALA | PRO | CYS | VAL | VAL | LYS | VAL | GLU | ||||
9 | PRO | SER | ASP | ASN | GLY | PRO | LEU | PHE | THR | GLU | ||||
10 | LEU | LYS | PHE | TYR | GLN | ARG | ALA | ALA | LYS | PRO | ||||
11 | GLU | GLN | ILE | GLN | LYS | TRP | ILE | ARG | THR | ARG | ||||
12 | LYS | LEU | LYS | TYR | LEU | GLY | VAL | PRO | LYS | TYR | ||||
13 | TRP | GLY | SER | GLY | LEU | HIS | ASP | LYS | ASN | GLY | ||||
14 | LYS | SER | TYR | ARG | PHE | MET | ILE | MET | ASP | ARG | ||||
15 | PHE | GLY | SER | ASP | LEU | GLN | LYS | ILE | TYR | GLU | ||||
16 | ALA | ASN | ALA | LYS | ARG | PHE | SER | ARG | LYS | THR | ||||
17 | VAL | LEU | GLN | LEU | SER | LEU | ARG | ILE | LEU | ASP | ||||
18 | ILE | LEU | GLU | TYR | ILE | HIS | GLU | HIS | GLU | TYR | ||||
19 | VAL | HIS | GLY | ASP | ILE | LYS | ALA | SER | ASN | LEU | ||||
20 | LEU | LEU | ASN | TYR | LYS | ASN | PRO | ASP | GLN | VAL | ||||
21 | TYR | LEU | VAL | ASP | TYR | GLY | LEU | ALA | TYR | ARG | ||||
22 | TYR | CYS | PRO | GLU | GLY | VAL | HIS | LYS | GLU | TYR | ||||
23 | LYS | GLU | ASP | PRO | LYS | ARG | CYS | HIS | ASP | GLY | ||||
24 | THR | ILE | GLU | PHE | THR | SER | ILE | ASP | ALA | HIS | ||||
25 | ASN | GLY | VAL | ALA | PRO | SER | ARG | ARG | GLY | ASP | ||||
26 | LEU | GLU | ILE | LEU | GLY | TYR | CYS | MET | ILE | GLN | ||||
27 | TRP | LEU | THR | GLY | HIS | LEU | PRO | TRP | GLU | ASP | ||||
28 | ASN | LEU | LYS | ASP | PRO | LYS | TYR | VAL | ARG | ASP | ||||
29 | SER | LYS | ILE | ARG | TYR | ARG | GLU | ASN | ILE | ALA | ||||
30 | SER | LEU | MET | ASP | LYS | CYS | PHE | PRO | GLU | LYS | ||||
31 | ASN | LYS | PRO | GLY | GLU | ILE | ALA | LYS | TYR | MET | ||||
32 | GLU | THR | VAL | LYS | LEU | LEU | ASP | TYR | THR | GLU | ||||
33 | LYS | PRO | LEU | TYR | GLU | ASN | LEU | ARG | ASP | ILE | ||||
34 | LEU | LEU | GLN | GLY | LEU | LYS | ALA | ILE | GLY | SER | ||||
35 | LYS | ASP | ASP | GLY | LYS | LEU | ASP | LEU | SER | VAL | ||||
36 | VAL | GLU | ASN | GLY | GLY | LEU | LYS | ALA | LYS | THR | ||||
37 | ILE | THR | LYS | LYS | ARG | LYS | LYS | GLU | ILE | GLU | ||||
38 | GLU | SER | LYS | GLU | PRO | GLY | VAL | GLU | ASP | THR | ||||
39 | GLU | TRP | SER | ASN | THR | GLN | THR | GLU | GLU | ALA | ||||
40 | ILE | GLN | THR | ARG | SER | ARG | THR | ARG | LYS | ARG | ||||
41 | VAL | GLN | LYS |
sample_1: entity, [U-13C; U-15N; U-2H; 1H ILE, LEU, VAL, ALA METHYL; 1H MET METHYL,GAMMA; 1H PHE EPSILON] VRK1, 0.4 mM; TRIS, [U-2H], 20 mM; sodium chloride 100 mM; glutamic acid 50 mM; arginine 50 mM; DTT, [U-2H], 1 mM; sodium azide 0.02%; H2O 90%; D2O 10%
sample_2: entity, [U-13C; U-15N; U-2H; 1H ILE, LEU, VAL METHYL; 1H PHE, TYR EPSILON] VRK1, 0.4 mM; TRIS, [U-2H], 20 mM; sodium chloride 100 mM; glutamic acid 50 mM; arginine 50 mM; DTT, [U-2H], 1 mM; sodium azide 0.02%; H2O 90%; D2O 10%
sample_3: entity, [U-15N; U-2H; 13C,1H ILE, LEU, VAL METHYL; 13C,1H PHE DELTA/EPSILON/ZETA] VRK1, 0.4 mM; TRIS, [U-2H], 20 mM; sodium chloride 100 mM; glutamic acid 50 mM; arginine 50 mM; DTT, [U-2H], 1 mM; sodium azide 0.02%; H2O 90%; D2O 10%
sample_4: entity, SAIL-VRK1, 0.4 mM; TRIS, [U-2H], 20 mM; sodium chloride 100 mM; glutamic acid 50 mM; arginine 50 mM; DTT, [U-2H], 1 mM; sodium azide 0.02%; H2O 90%; D2O 10%
sample_conditions_1: ionic strength: 120 mM; pH: 7.0; pressure: 1 atm; temperature: 298 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D 1H-15N NOESY | sample_1 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY | sample_1 | isotropic | sample_conditions_1 |
3D 13C-13C NOESY | sample_1 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_2 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY | sample_2 | isotropic | sample_conditions_1 |
3D 13C-13C NOESY | sample_3 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY | sample_4 | isotropic | sample_conditions_1 |
TOPSPIN, Bruker Biospin - collection
NMRPipe, Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax - processing
AZARA, Boucher - processing
NMRView, Johnson, One Moon Scientific - data analysis
Kujira, N. Kobayashi - data analysis
CNS, Brunger, Adams, Clore, Gros, Nilges and Read - structure solution
BMRB | 16715 16738 |
PDB | |
DBJ | BAA19108 BAF82799 BAI47070 |
GB | AAI03762 AAI12076 AAI13511 AAQ02593 AIC55301 |
REF | NP_001244605 NP_003375 XP_003902302 XP_004055717 XP_005562233 |
SP | Q99986 |
AlphaFold | Q99986 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks